Skip to main content

The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects



While cystic fibrosis (CF) is the most common cause of bronchiectasis in childhood, non-CF bronchiectasis is associated with a wide variety of disorders. The objective of this study was to determine the relative prevalence and specific etiologies on non-CF bronchiectasis in childhood.


EMBASE, Medline, OVID Cochrane Reviews, Directory of Open Access Journals, Open Science Directory, EPSCO information services, and OAlster were searched electronically and the bibliographies of selected studies were searched manually. The search was conducted independently by 2 authors. Study Selection: (1) any clinical trial, observational study or cross-sectional case series of 10 or more patients with a description of the conditions associated with bronchiectasis; (2) subjects aged 21 years or younger; (3) cystic fibrosis was excluded and; (4) the diagnosis was confirmed by computed tomography of the chest. Data Extraction: Patient number, age range, inclusion criteria, diagnostic criteria, patient source, and categorical and specific etiology.


From 491 studies identified, 12 studies encompassing 989 children with non-CF bronchiectasis were selected. Sixty-three percent of the subjects had an underlying disorder. Infectious (17%), primary immunodeficiency (16%), aspiration (10%), ciliary dyskinesia (9%), congenital malformation (3%), and secondary immunodeficiency (3%) were the most common disease categories; 999 etiologies were identified. Severe pneumonia of bacterial or viral etiology and B cell defects were the most common disorders identified.


The majority of children with non-CF bronchiectasis have an underlying disorder. A focused history and laboratory investigated is recommended.

Peer Review reports


Bronchiectasis in children without cystic fibrosis (non-CF bronchiectasis) is believed to be the end result of chronic or repeated episodes of environmental insults superimposed on a background of “genetic vulnerability”; these events lead to bronchial injury and dilatation [1]. In 1963, Clark described 116 cases of bronchiectasis in children aged 0 to 11 years [2]. See of those cases with an apparent etiology, most followed episodes of measles or pertussis. Radiographic evaluation of these children yielded a mixed picture: 1 child had collapse of an entire lung; 12 children had pulmonary cavitation with or without accompanying atelectasis and; 34 children had lobar atelectasis. Bronchography demonstrated bronchiectasis in all subjects tested.

The underlying “vulnerabilities” in children are poorly defined. McDonnell, et al. generated a list of disorders that included immunodeficiency, connective tissue disorders, allergic bronchopulmonary aspergillosis as well as miscellaneous conditions including amyloidosis and endometriosis [3]. In another review, autoimmune disorders, primary ciliary dyskinesia, hypersensitivity syndromes, connective tissue disorders, and malignancy were listed among the potential causes of non-CF bronchiectasis [4]. In both cases, the etiologies listed were not specific for children and were not empirically derived. The goals of this systematic review were to determine the specific etiologies and relative prevalence of these disorders among children with non-CF bronchiectasis from studies reported in the literature.



This study followed the Preferred Reporting Items in Systematic Reviews and Meta-Analyses (PRISMA) guidelines [5].


The study protocol was developed by the authors a priori. The inclusion criteria for this review were: (1) any clinical trial, observational study or cross-sectional case series of 10 or more patients that included a delineation of the etiologies and/or the associated conditions with bronchiectasis; (2) subjects aged 21 years or younger; (3) cystic fibrosis was excluded as a diagnosis and; (4) the diagnosis of bronchiectasis was confirmed by computed tomography of the chest. Studies of adults and children were acceptable if the pediatric data was reported separately. Case reports, editorials and review articles were excluded.

Information sources

EMBASE, Medline, OVID Cochrane Reviews, Directory of Open Access Journals, Open Science Directory, EPSCO information services, and OAlster were searched from 1966 to March 25, 2014. The bibliographies of all of the selected studies were also reviewed.


The main search term was “non-CF bronchiectasis”. The following filters were used: human, all children and young adult. The searches were performed independently by two of the authors and the results were compared.

Study selection

Initial evaluation of each article was performed by one author (KSB) and then reviewed by another (MTD). In cases where study populations appeared to overlap, the study with the largest number of subjects was selected. Differences in judgment were resolved first by consensus; ties were adjudicated by the third author (SCA). All studies selected for inclusion were reviewed by the third author.

Data collection

For each selected study, the following information was recorded: inclusion criteria, number of patients, age range, diagnostic criteria, patient source and country of origin. Categorical and specific etiologies of bronchiectasis were also recorded for each study. Major categories of disease included primary immunodeficiencies, ciliary dyskinesia, infection, aspiration, idiopathic or unknown, congenital malformation, secondary immunodeficiencies, asthma, skeletal disorders, bronchiolitis obliterans, and others. Within each category, specific etiologies were catalogued from those studies that provided specific data.

Synthesis of results

The categorical and specific etiologies of non-CF bronchiectasis were pooled to provide estimates of the relative prevalence for each disorder. Total sample size estimates for categorical comparisons were calculated from the total number of etiologies identified for the entire review. Total sample size estimates for the comparison of specific etiologies within individual categories were calculated from the total number of etiologies reported in a given category.

Sources of bias across studies

Patient sampling by number, locale and institution raised the concern of population homogeneity and possible over- or under-representation of a specific area or ethnic group. Variability in diagnostic evaluation and the identification of multiple etiologies for individual patients were also potential sources of bias in defining etiology. Inconsistencies and vagaries in nomenclature were a potential source of error when studies were combined.

Results and discussion

Study selection

The results of the literature search are shown in Figure 1. Searches of the Medline and EMBASE databases yielded 202 references. An additional 289 citations were found by extensively searching the bibliographies of selected articles (Additional file 1). No additional studies were found by searching the OVID Cochrane Reviews, Directory of Open Access Journals, Open Science Directory, EPSCO information services, or OAlster. From the 491 studies identified, 448 studies were excluded after a cursory review of the title, abstract, and, when necessary, the results section. The full text of the remaining 43 articles was reviewed in detail. Thirty- one of the remaining studies were excluded: 22 reports had overlapping populations with other studies; 3 did not use computed tomography for the diagnosis of bronchiectasis; 1 did not have the minimum number of patients; 2 studies included the same subjects as previous publications; 2 included adult populations that could not be separated from the pediatric subjects and; 1 did not contain any etiology data.

Figure 1

Results of literature search.

Study characteristics and outcomes

The characteristics of the 12 studies that met the inclusion criteria and comprise the basis of this review are shown in Table 1 [6]-[17]. The reports ranged in size from 22 to 151 participants per study. Non-CF bronchiectasis was defined by computed tomography [18]; in one study, 96% of patients underwent computed tomography [6]. Together, these reports represent a worldwide sample (Australia, Ireland, Turkey, Saudi Arabia, United Kingdom, New Zealand, Alaska, Italy, and Korea). Children were drawn from single centers in 8 studies [6]-[12],[16], multiple centers in 3 studies [13]-[15] and an entire region in 1 study [17]; the total number of patients included in this review is 989.

Table 1 Summary of Included studies

The underlying conditions associated with non-CF bronchiectasis in children, by study, are shown in Table 2. Banjar, et al. and Eastham et al. reported multiple associations in individual patients [6],[7]. Attempts to contact the authors were unsuccessful. With the inclusion of these studies, the total number of associations (994) exceeds the total number of patients reported (989). In two studies, the most likely association of multiple associations reported for individual patients was the only one counted (e.g. primary immunodeficiency is a more likely association than infection since it was the likely predisposition for the infection) [7],[8]. Singleton et al. described patients with definite and probable bronchiectasis [16]; only definite cases were included.

Table 2 Etiology of non-CF Bronchiectasis in childhood by study

Synthesis of results

The categorical disease processes associated with childhood non-CF bronchiectasis are shown in Table 3. Nine hundred and ninety nine associations were identified in 989 patients. No association was found in 366 subjects (40%). Of the identified associations, the most common were infection (173 subjects, 19%), primary immunodeficiency (160 subjects, 18%), aspiration/foreign body (95 subjects, 10%) and ciliary dyskinesia, including Kartagener’s Syndrome (91 subjects, 10%).

Table 3 Summary of associations with non-CF bronchiectasis of childhood by disease category (989 patients with 994 associations)

The infections associated with non-CF bronchiectasis are shown in Table 4. Of the 173 patients with an infectious process, 108 (62%) were identified by a specific disease entity. Pneumonia was the most common association (61%) followed by measles (14%), tuberculosis (11%) and pertussis (5%). Varicella, neonatal pneumonia, allergic bronchopulmonary aspergillosis and adenoviral pneumonia were rarely associated with bronchiectasis.

Table 4 Infectious diseases associated with non-CF bronchiectasis of childhood (n = 108)

Of the 160 children with bronchiectasis and primary immunodeficiency, 131 (83%) cases were identified by a specific entity (Table 5). B cell disorders accounted for 97 (73.5%) of the primary immunodeficiencies identified: IgG and IgG subclass deficiencies were the most common (66.5%) and IgA deficiency accounted for 6%. A heterogeneous group of combined immunodeficiency disorders accounted for 10% of cases while 7.5% of primary immunodeficiencies resulted from T cell disorders. Of the 29 subjects with secondary immunodeficiencies, 18 (62%) were children who had received chemotherapy for an underlying oncologic process; 6 (20%) of children had HIV/AIDS and 5 (18%) were cardiac transplant recipients.

Table 5 Primary immunodeficiencies associated with non-CF bronchiectasis in childhood (n = 131)

Of the 95 children with bronchiectasis and aspiration, 18 instances (20%) resulted from aspiration of a foreign body; 14 children (15%) had seizures and recurrent aspiration. Thirty-four children had an underlying congenital malformation and 27 (79%) had a specific entity identified (Table 6). Tracheoesophageal fistulae and cystic lung disease accounted for 52% and 19% of cases, respectively.

Table 6 Congenital malformations associated with non-CF bronchiectasis of childhood

Risk of bias

The studies included in this review ranged in size from 22 to 151 subjects; the largest study accounted for 17% of the total sample. The countries of origin contributed samples from 9 different countries and multiple continents. Only 1 study drew patients from a large, regional database; the remaining studies represented one or two clinical sites. All of the studies were retrospective in nature and none employed a standardized diagnostic evaluation. Vagaries in nomenclature occurred among patients diagnosed with primary immunodeficiencies deficiencies. Patients with antibody deficiency, antibody dysfunction or IgG deficiency were grouped together as IgG deficiency; those with combined immunodeficiency were grouped together with severe combined immunodeficiency. Identifying patients with “idiopathic” disease is also confusing since this implies a singular, as yet unidentified process. Three studies reported multiple underlying disorders for individual patients with non-CF bronchiectasis [6]-[8]. In two, patients with multiple ascribed etiologies could not be identified [6],[7].

Non-CF bronchiectasis in children usually has an indolent onset and presents with chronic respiratory symptoms [2]-[4]. Cough with daily sputum production is the most common clinical presentation and may be present for years before diagnosis. Hemoptysis, pleuritic chest pain, pulmonary osteoarthropathy, and delayed growth are additional findings associated with non-CF bronchiectasis. The definitive diagnosis of bronchiectasis requires chest imaging usually with high resolution computed tomography [18].

While the pathophysiology of bronchiectasis is well defined, the etiologies of non-CF bronchiectasis are varied [1],[3]. The data presented in this review suggest that 60% of children with this disorder have an underlying etiology. Infections, primary immunodeficiencies, aspiration (both foreign body and recurrent aspiration in neurodevelopmentally challenged patients) and ciliary dyskinesia account for most cases; severe bacterial or viral pneumonias and IgG deficiencies are the most common etiologies encountered. Throughout the literature, patients without an identified etiology are reported as idiopathic disease. A focused medical history and focused laboratory investigation should reveal the etiology of non-CF bronchiectasis in many cases.

Selection bias is a major limitation of this review. Since all of the studies selected for review were retrospective in design, the possibility exists that patients may have been missed. The subjects included in this study represent 9 different countries, lending credence to the notion that the sample is unbiased. Conversely, U.S. children are underrepresented since the only American study was from Alaska. Finally, 8 of the studies selected for review reported patients from a single clinical site and 3 studies used 2 clinical sites; only 1 study employed a regional database [17].

Misidentification and failure to identify an etiology also contribute to the limitation of this review. Identifying multiple etiologies in individual patients occurred in 2 studies, raising the concern of over representation of specific etiologies [6],[7]. The selected studies contained little to no detail regarding the diagnostic approach used to identify the etiology of non-CF bronchiectasis. The absence of a detailed, unified approach to the diagnostic evaluation of these children across studies may have overestimated the number of children without a diagnosis or may have misdiagnosed an unknown number of subjects. Variability in nomenclature compounds this problem. The most common etiology of non-CF bronchiectasis was severe pneumonia, but detail regarding the infectious agent was not available. The second most common etiology was a B cell disorder; unfortunately some subjects were identified with IgG deficiency or an antibody disorder leaving the true diagnosis open to speculation.


The majority of children with non-CF bronchiectasis have an underlying cause of the disorder. Severe pneumonia, B cell abnormalities, recurrent aspiration or aspiration of a foreign body and ciliary dyskinesia are the most common etiologies. A focused history and laboratory investigation is suggested in the evaluation of these children. A large prospective study with a predefined diagnostic evaluation is required to substantiate the conclusions of this review.


This study did not involve any direct contact with primary patient source documents and as such did not require IRB approval or patient consent.

Additional file



Cystic fibrosis


Preferred reporting items in systematic reviews and meta-analyses


  1. 1.

    Cole PJ: Inflammation: a two-edged sword-the model of bronchiectasis. Eur J Respir Dis Suppl. 1986, 147: 6-15.

    CAS  PubMed  Google Scholar 

  2. 2.

    Clark NS: Bronchiectasis in childhood. BMJ. 1963, 1: 80-88. 10.1136/bmj.1.5323.80.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    McDonnell MJ, Ward C, Lordan JL, RM R: Non-cystic fibrosis bronchiectasis. Q J Med. 2013, 106: 709-715. 10.1093/qjmed/hct109.

    CAS  Article  Google Scholar 

  4. 4.

    McShane PJ, Naureckas ET, Tino G, ME S: Non-cystic fibrosis bronchiectasis. Amer J REspir Crit Care Med. 2013, 188: 647-656. 10.1164/rccm.201303-0411CI.

    Article  Google Scholar 

  5. 5.

    Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gøtzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D: The PRISMA statment for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009, 339: b2700-10.1136/bmj.b2700.

    Article  PubMed  PubMed Central  Google Scholar 

  6. 6.

    Banjar HH: Clinical profile of Saudi children with bronchiectasis. Indian J Pediatr. 2007, 74: 149-152. 10.1007/s12098-007-0008-z.

    Article  PubMed  Google Scholar 

  7. 7.

    Eastham KM, Fall AJ, Mitchell L, Spencer DA: The need to redefine non-cystic fibrosis bronchiectasis in childhood. Thorax. 2004, 59: 324-327. 10.1136/thx.2003.011577.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  8. 8.

    Gaillard EA, Carty H, Heaf D, Smyth RL: Reversible bronchial dilatation in children: comparison of serial high-resolution computer tomography scans of the lungs. Eur J Radiol. 2003, 47: 215-220. 10.1016/S0720-048X(02)00122-5.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Kapur N, Grimwood K, Masters IB, Morris PS, Chang AB: Lower airway microbiology and cellularity in children with newly diagnosed non-CF bronchiectasis. Pediatr Pulmonol. 2012, 47: 300-307. 10.1002/ppul.21550.

    Article  PubMed  Google Scholar 

  10. 10.

    Karadag B, Karakoc F, Ersu R, Kut A, Bakac S, Dagli E: Non-cystic-fibrosis bronchiectasis in children: a persisting problem in developing countries. Respiration. 2005, 72: 233-238. 10.1159/000085362.

    CAS  Article  PubMed  Google Scholar 

  11. 11.

    Karakoc GB, Inal A, Yilmaz M, Altintas DU, Kendirli SG: Exhaled breath condensate MMP-9 levels in children with bronchiectasis. Pediatr Pulmonol. 2009, 44: 1010-1016. 10.1002/ppul.21096.

    Article  PubMed  Google Scholar 

  12. 12.

    Koh YY, Lee MH, Sun YH, Sung KW, Chae JH: Effect of roxithromycin on airway responsiveness in children with bronchiectasis: a double-blind, placebo-controlled study. Eur Respir J. 1997, 10: 994-999. 10.1183/09031936.97.10050994.

    CAS  Article  PubMed  Google Scholar 

  13. 13.

    Li AM, Sonnappa S, Lex C, Wong E, Zacharasiewicz A, Bush A, Jaffe A: Non-CF bronchiectasis: does knowing the aetiology lead to changes in management?. Eur Respir J. 2005, 26: 8-14. 10.1183/09031936.05.00127704.

    Article  PubMed  Google Scholar 

  14. 14.

    Munro KA, Reed PW, Joyce H, Perry D, Twiss J, Byrnes CA, Edwards EA: Do New Zealand children with non-cystic fibrosis bronchiectasis show disease progression?. Pediatr Pulmonol. 2011, 46: 131-138. 10.1002/ppul.21331.

    Article  PubMed  Google Scholar 

  15. 15.

    Santamaria F, Montella S, Pifferi M, Ragazzo V, De Stefano S, De Paulis N, Maglione M, Boner AL: A descriptive study of non-cystic fibrosis bronchiectasis in a pediatric population from central and southern Italy. Respiration. 2009, 77: 160-165. 10.1159/000137510.

    Article  PubMed  Google Scholar 

  16. 16.

    Singleton R, Morris A, Redding G, Poll J, Holck P, Martinez P, Kruse D, Bulkow LR, Peterson KM, Lewis C: Bronchiectasis in Alaska native children: causes and clinical courses. Pediatr Pulmonol. 2000, 29: 182-187. 10.1002/(SICI)1099-0496(200003)29:3<182::AID-PPUL5>3.0.CO;2-T.

    CAS  Article  PubMed  Google Scholar 

  17. 17.

    Zaid AA, Elnazir B, Greally P: A decade of non-cystic fibrosis bronchiectasis 1996–2006. Ir Med J. 2010, 103: 77-79.

    CAS  PubMed  Google Scholar 

  18. 18.

    Lucidarme O, Grenier P, Coche E, Lenoir S, Aubert B, Beigelman C: Bronchiectasis: comparative assessment with thin-section CT and helical CT. Radiology. 1996, 200: 673-679. 10.1148/radiology.200.3.8756913.

    CAS  Article  PubMed  Google Scholar 

Download references

Author information



Corresponding author

Correspondence to Stephen C Aronoff.

Additional information

Competing interests

The authors declare that they have no competing interests.

Authors’ contributions

KSB participated in the design of the study, performed a literature search, participated in study selection, extracted the data and drafted the initial manuscript. MTD participated in the design of the study, performed a literature search, participated in study selection and, reviewed the data extraction. SCA conceptualized the study, participated in the design of the study, participated in study selection and revised the final manuscript. All authors read and approved the final manuscript as submitted and agree to be accountable for all aspects of the work.

Electronic supplementary material

Authors’ original submitted files for images

Below are the links to the authors’ original submitted files for images.

Authors’ original file for figure 1

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Brower, K.S., Del Vecchio, M.T. & Aronoff, S.C. The etiologies of non-CF bronchiectasis in childhood: a systematic review of 989 subjects. BMC Pediatr 14, 299 (2014).

Download citation


  • Non-CF bronchiectasis
  • Children
  • Etiology